Showing 1 to 2 of 2 results


New Drug Baxdrostat Shows Significant Blood Pressure Reduction in Resistant Hypertension
A new drug, baxdrostat, has demonstrated significant blood pressure reduction in a global trial involving 796 patients with resistant hypertension, lowering systolic blood pressure by approximately 9-10 mmHg and achieving normal blood pressure in roughly 40% of patients.
New Drug Baxdrostat Shows Significant Blood Pressure Reduction in Resistant Hypertension
A new drug, baxdrostat, has demonstrated significant blood pressure reduction in a global trial involving 796 patients with resistant hypertension, lowering systolic blood pressure by approximately 9-10 mmHg and achieving normal blood pressure in roughly 40% of patients.
Progress
52% Bias Score

New Drug Shows Promise in Treating Resistant High Blood Pressure
An experimental drug, baxdrostat, effectively lowered blood pressure in a clinical trial involving 800 adults with resistant hypertension, offering a potential new treatment option.

New Drug Shows Promise in Treating Resistant High Blood Pressure
An experimental drug, baxdrostat, effectively lowered blood pressure in a clinical trial involving 800 adults with resistant hypertension, offering a potential new treatment option.
Progress
24% Bias Score
Showing 1 to 2 of 2 results